RE:RE:HEXO Quarter Report Dateswhich is - of course - an idiotic comparison.
Last year's year end sales figures did not include Zenabis, 48N or Redecan.
After spending $1.5 billion on acquisitions to grow revenue - they SHOULD show an increase. Unfortunately for Hexo investors - all 3 acquistions have shown a drop in annual sales, inclduing Hexo's own sales.
Regardless - they key is the bottom line, amd Hexo's ytd at the end of Q3 shows a NET LOSS of $900 million.
A quick review of their last financials will also show that it costs more for Hexo to produce a product than what they are able to sell it for. Operating expenses - the araes where 'synergies' were suppsoed to be realzied have actually increased and Hexo has publicly admitted they'll never achieve those cost saving synergies they so loudly boasted about with each deal/acquisition.
quinlash - (10/3/2022 1:30:45 PM)
RE:HEXO Quarter Report Dates
As noted, the actual reporting dates have not been provided by the company. It is to their discression when they actually report as long as the date is no later than the 29th.
In terms of "Good News" vs "Bad News" we can look back over the 2021 Year End Number and compare those to the current running totals for 2022. It is clear that year over year numbers will show no less than a 50% increase in both Gross and Net Sales figures as it stands at the moment.